Floaters Relief
- Manufacturer
- TRP Company
- Effective date
- 2022-08-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:55:42
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
| Active Ingredients | Purpose |
| Chelidonium HPUS 6x | Floaters obstructing vision |
| Physostigma HPUS 12x | Shapes in vision |
| Euphrasia HPUS 6x | Irritation |
| Kali Sulph. HPUS 10x | Squiggly lines in vision |
| Natrium muriaticum HPUS 10x | Floaters in vision |
| Phosphorus HPUS 12x | Dark dots in vision |
| Silicea HPUS 12x | Blurry vision |
| Sepia HPUS 7x | Dust particles |
"HPUS" indicates the active ingredients are in the Homeopathic Pharmacopoeia of the United States.
INDICATIONS & USAGE SECTION
Uses:*
According to homeopathic indications these ingredients provide temporary relief from symptoms such as:
• Floaters • Squiggly lines in vision • Irritation • Dark dots in vision • Shapes in vision • Dust particles in vision; after serious causes have been ruled out by a physician.
*These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
WARNINGS SECTION
Warnings:
A PHYSICIAN SHOULD ALWAYS BE CONSULTED TO RULE OUT SERIOUS CAUSES.
For External Use Only.
- This product is intended to complement not replace, standard medical treatment.
- Initial worsening of symptoms may occur.
OTC - PREGNANCY OR BREAST FEEDING SECTION
- If pregnant or breast-feeding, ask a health professional before use.
WARNINGS SECTION
- Contact lens wearers consult physician before use.
- To avoid contamination - do not touch tip to any surface.
- Replace cap after every use.
- Use within 30 days of opening.
- EXPIRATION DATE ONLY REFERS TO THE UNOPENED BOTTLE.
- The use of this container by more than one person may spread infection.
Do not use:
- If solution changes color or becomes cloudy.
- If you frequently contract infections that do not clear up easily.
- If you experience eye pain or changes in vision.
Stop use and ask a doctor if:
- You experience eye pain or change in vision, continued shapes, or floaters in vision.
- The condition worsens.
- Symptoms last longer than 72 hours.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children
• In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions:
• Suitable for adults and children ages 2 and over. Children under the age of 2: Consult a physician before use. Squeeze 1-3 drops in the eye. Use several times per day as needed. Homeopathic remedies may not be effective for everyone. Individual results may vary.
SPL UNCLASSIFIED SECTION
Other information:
- Non-prescription drug products cannot treat infections.
- Store at room temperature 15° to 30° C (59° to 86°F). • Keep bottle tightly closed. • Active ingredients are micro-diluted in accordance with the Homeopathic Pharmacopoeia of the United States and are therefore non-toxic with no known side effects or contraindications. • Eye Floaters
® Homeopathic Sterile Eye Drops are homeopathic dilutions, for details see
www.thereliefproducts.com.
INACTIVE INGREDIENT SECTION
Inactive Ingredients:
Benzalkonium Chloride (preservative), Purified water, Sodium Chloride, Sodium Phosphate DiBasic, Sodium Phosphate Monobasic
Questions or comments?
www.thereliefproducts.com, 1-888-969-6855
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17312-098-15 | 2025-11-17 | C162847 | 48780-1 | 1e7a6dab-1666-a2ce-e063-dadaa90aadf7 | Natural Eyes Floaters Relief TM |
| 17312-098-15 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-1666-a2ce-e063-dadaa90aadf7 | Natural Eyes Floaters Relief TM |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17312-098 | FLOATERS RELIEF (CHELIDONIUM MAJUS, PHYSOSTIGMA VENENOSUM SEED, EUPHRASIA STRICTA,POTASSIUM SULFATE, SODIUM CHLORIDE, PHOSPHORUS, SILICON DIOXIDE, SEPIA OFFICINALIS JUICE) LIQUID [TRP COMPANY] | 1 | Legacy NDC | 20220811_e5d71b42-a314-8d35-e053-2a95a90a85b4.zip |
Products#
Every source-derived product name is available through these pages.
- Floaters Relief
- CHELIDONIUM MAJUS, PHYSOSTIGMA VENENOSUM SEED, EUPHRASIA STRICTA,POTASSIUM SULFATE, SODIUM CHLORIDE, PHOSPHORUS, SILICON DIOXIDE, SEPIA OFFICINALIS JUICE
- SILICON DIOXIDE
- BENZALKONIUM CHLORIDE
- WATER
- SODIUM PHOSPHATE, DIBASIC
- SODIUM PHOSPHATE, MONOBASIC
- SEPIA OFFICINALIS JUICE
- CHELIDONIUM MAJUS
- PHOSPHORUS
- SODIUM CHLORIDE
- SODIUM CATION
- POTASSIUM SULFATE
- POTASSIUM CATION
- EUPHRASIA STRICTA
- PHYSOSTIGMA VENENOSUM SEED
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17312-098 | 17312-098-15 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILICON DIOXIDE | ETJ7Z6XBU4 | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | IACT |
| SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | IACT |
| SEPIA OFFICINALIS JUICE | QDL83WN8C2 | ACTIB |
| CHELIDONIUM MAJUS | 7E889U5RNN | ACTIB |
| PHOSPHORUS | 27YLU75U4W | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| POTASSIUM SULFATE | 1K573LC5TV | ACTIB |
| EUPHRASIA STRICTA | C9642I91WL | ACTIB |
| PHYSOSTIGMA VENENOSUM SEED | CJV9E9IIOA | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 43d308bb-fa8f-9f9d-e063-6394a90ab45b | e5d71b42-a314-8d35-e053-2a95a90a85b4 | 2025-11-17 | Warnings | e5d71b42-a314-8d35-e053-2a95a90a85b4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

